Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

LAMEA Automated and Closed Cell Therapy Processing Systems Market By type (stem cell therapy, and non-stem cell therapy), By workflow (separation, expansion, apheresis, fill-finish, cryopreservation and others), By scale (Pre-commercial/R&D Scale and Commercial Scale), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

Published Date : 22-Dec-2021

Pages: 98

Formats: PDF

The Latin America, Middle East and Africa Automated And Closed Cell Therapy Processing Systems Market would witness market growth of 21.5% CAGR during the forecast period (2021-2027).

Automated systems would allow constant supervision of controlled therapy processing that is being performed for the development of the latest therapeutic platforms. Also, integrated intelligent algorithms also help in offering high accuracy. Companies operating in this industry are highly engaging in the development of infrastructure to support the production of automated systems.

Factors like rising healthcare investments and growing advancements in medical therapies are anticipated to fuel the growth of the regional automated and closed cell therapy processing systems market. In addition, the increase in investment by government institutions and companies for the development of advanced regenerative and cell therapies would fuel the growth of the regional market in the coming years. Also, specification or customization of medicine is becoming more popular across various nations of this region, which would spur the growth of the regional market during the forecast period.

The Brazil market dominated the LAMEA Automated and Closed Cell Therapy Processing Systems Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $48.4 million by 2027. The Argentina market is poised to grow a CAGR of 22.2% during (2021 - 2027). Additionally, the UAE market would expect a CAGR of 21.2% during (2021 - 2027).

Based on type, the market is segmented into stem cell therapy, and non-stem cell therapy. Based on workflow, the market is segmented into separation, expansion, apheresis, fill-finish, cryopreservation and others. Based on scale, the market is segmented into Pre-commercial/R&D Scale and Commercial Scale..Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Automated and Closed Cell Therapy Processing Systems Market is Predict to reach $37.9 billion by 2027, at a CAGR of 32.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Lonza Group AG, Terumo Corporation, Cytiva (Danaher Corporation), Thermo Fisher Scientific, Inc., Miltenyi Biotec B.V. & Co. KG, Thermogenesis Holdings, Inc., Cellares Inc., Biospherix ltd., Sartorius AG, and Fresenius SE & Co. KGaA.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Separation
  • Expansion
  • Apheresis
  • Fill-Finish
  • Cryopreservation

By Workflow

  • Stem Cell Therapy
  • Non-Stem Cell Therapy

By Scale

  • Pre-commercial/R&D Scale
  • Commercial Scale

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Lonza Group AG
  • Terumo Corporation
  • Cytiva (Danaher Corporation)
  • Thermo Fisher Scientific, Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Thermogenesis Holdings, Inc.
  • Cellares Inc.
  • Biospherix ltd.
  • Sartorius AG
  • Fresenius SE & Co. KGaA
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Automated And Closed Cell Therapy Processing Systems Market, by workflow
1.4.2 LAMEA Automated And Closed Cell Therapy Processing Systems Market, by type
1.4.3 LAMEA Automated And Closed Cell Therapy Processing Systems Market, by Scale
1.4.4 LAMEA Automated And Closed Cell Therapy Processing Systems Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2018, Feb – 2021, Oct) Leading Players

Chapter 4. LAMEA Automated and Closed Cell Therapy Processing Systems Market by Type
4.1 LAMEA Non-Stem Cell Therapy Market by Country
4.2 LAMEA Stem Cell Therapy Market by Country

Chapter 5. LAMEA Automated and Closed Cell Therapy Processing Systems Market by Workflow
5.1 LAMEA Expansion Market by Country
5.2 LAMEA Separation Market by Country
5.3 LAMEA Apheresis Market by Country
5.4 LAMEA Cryopreservation Market by Country
5.5 LAMEA Fill- Finish Market by Country
5.6 LAMEA Others Market by Country

Chapter 6. LAMEA Automated and Closed Cell Therapy Processing Systems Market by Scale
6.1 LAMEA Pre-commercial/ R&D Scale Market by Country
6.2 LAMEA Commercial Scale Market by Country

Chapter 7. LAMEA Automated and Closed Cell Therapy Processing Systems Market by Country
7.1 Brazil Automated and Closed Cell Therapy Processing Systems Market
7.1.1 Brazil Automated and Closed Cell Therapy Processing Systems Market by Type
7.1.2 Brazil Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.1.3 Brazil Automated and Closed Cell Therapy Processing Systems Market by Scale
7.2 Argentina Automated and Closed Cell Therapy Processing Systems Market
7.2.1 Argentina Automated and Closed Cell Therapy Processing Systems Market by Type
7.2.2 Argentina Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.2.3 Argentina Automated and Closed Cell Therapy Processing Systems Market by Scale
7.3 UAE Automated and Closed Cell Therapy Processing Systems Market
7.3.1 UAE Automated and Closed Cell Therapy Processing Systems Market by Type
7.3.2 UAE Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.3.3 UAE Automated and Closed Cell Therapy Processing Systems Market by Scale
7.4 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market
7.4.1 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market by Type
7.4.2 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.4.3 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market by Scale
7.5 South Africa Automated and Closed Cell Therapy Processing Systems Market
7.5.1 South Africa Automated and Closed Cell Therapy Processing Systems Market by Type
7.5.2 South Africa Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.5.3 South Africa Automated and Closed Cell Therapy Processing Systems Market by Scale
7.6 Nigeria Automated and Closed Cell Therapy Processing Systems Market
7.6.1 Nigeria Automated and Closed Cell Therapy Processing Systems Market by Type
7.6.2 Nigeria Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.6.3 Nigeria Automated and Closed Cell Therapy Processing Systems Market by Scale
7.7 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market
7.7.1 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market by Type
7.7.2 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.7.3 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market by Scale

Chapter 8. Company Profiles
8.1 Lonza Group AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Terumo Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.3 Cytiva (Danaher Corporation)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Miltenyi Biotech B.V. & Co. KG
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.5.2.2 Product Launches and Product Expansions:
8.5.2.3 Acquisition and Mergers:
8.6 ThermoGenesis Holdings, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.7 Cellares, Inc.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Biospherix ltd.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 Sartorius AG
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Product Launches and Product Expansions:
8.1 Fresenius SE & Co. KGaA
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Acquisition and Mergers:
TABLE 1 LAMEA Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Automated And Closed Cell Therapy Processing Systems Market
TABLE 4 Product Launches And Product Expansions– Automated And Closed Cell Therapy Processing Systems Market
TABLE 5 Acquisition and Mergers– Automated And Closed Cell Therapy Processing Systems Market
TABLE 6 LAMEA Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 7 LAMEA Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 8 LAMEA Non-Stem Cell Therapy Market by Country, 2017 - 2020, USD Million
TABLE 9 LAMEA Non-Stem Cell Therapy Market by Country, 2021 - 2027, USD Million
TABLE 10 LAMEA Stem Cell Therapy Market by Country, 2017 - 2020, USD Million
TABLE 11 LAMEA Stem Cell Therapy Market by Country, 2021 - 2027, USD Million
TABLE 12 LAMEA Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 13 LAMEA Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 14 LAMEA Expansion Market by Country, 2017 - 2020, USD Million
TABLE 15 LAMEA Expansion Market by Country, 2021 - 2027, USD Million
TABLE 16 LAMEA Separation Market by Country, 2017 - 2020, USD Million
TABLE 17 LAMEA Separation Market by Country, 2021 - 2027, USD Million
TABLE 18 LAMEA Apheresis Market by Country, 2017 - 2020, USD Million
TABLE 19 LAMEA Apheresis Market by Country, 2021 - 2027, USD Million
TABLE 20 LAMEA Cryopreservation Market by Country, 2017 - 2020, USD Million
TABLE 21 LAMEA Cryopreservation Market by Country, 2021 - 2027, USD Million
TABLE 22 LAMEA Fill- Finish Market by Country, 2017 - 2020, USD Million
TABLE 23 LAMEA Fill- Finish Market by Country, 2021 - 2027, USD Million
TABLE 24 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 25 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 26 LAMEA Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 27 LAMEA Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 28 LAMEA Pre-commercial/ R&D Scale Market by Country, 2017 - 2020, USD Million
TABLE 29 LAMEA Pre-commercial/ R&D Scale Market by Country, 2021 - 2027, USD Million
TABLE 30 LAMEA Commercial Scale Market by Country, 2017 - 2020, USD Million
TABLE 31 LAMEA Commercial Scale Market by Country, 2021 - 2027, USD Million
TABLE 32 LAMEA Automated and Closed Cell Therapy Processing Systems Market by Country, 2017 - 2020, USD Million
TABLE 33 LAMEA Automated and Closed Cell Therapy Processing Systems Market by Country, 2021 - 2027, USD Million
TABLE 34 Brazil Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 35 Brazil Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 36 Brazil Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 37 Brazil Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 38 Brazil Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 39 Brazil Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 40 Brazil Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 41 Brazil Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 42 Argentina Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 43 Argentina Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 44 Argentina Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 45 Argentina Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 46 Argentina Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 47 Argentina Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 48 Argentina Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 49 Argentina Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 50 UAE Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 51 UAE Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 52 UAE Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 53 UAE Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 54 UAE Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 55 UAE Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 56 UAE Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 57 UAE Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 58 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 59 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 60 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 61 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 62 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 63 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 64 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 65 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 66 South Africa Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 67 South Africa Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 68 South Africa Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 69 South Africa Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 70 South Africa Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 71 South Africa Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 72 South Africa Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 73 South Africa Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 74 Nigeria Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 75 Nigeria Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 76 Nigeria Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 77 Nigeria Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 78 Nigeria Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 79 Nigeria Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 80 Nigeria Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 81 Nigeria Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 82 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 83 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 84 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 85 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 86 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 87 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 88 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 89 Rest of LAMEA Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 90 Key Information – Lonza Group AG
TABLE 91 Key Information – Terumo Corporation
TABLE 92 Key Information – Cytiva
TABLE 93 Key Information – Thermo Fisher Scientific, Inc.
TABLE 94 Key information – Miltenyi Biotec B.V. & Co. KG
TABLE 95 Key information – THERMOGENESIS HOLDINGS, INC.
TABLE 96 Key information – Cellares, Inc.
TABLE 97 Key information – Biospherix ltd.
TABLE 98 Key Information – Sartorius AG
TABLE 99 key information – Fresenius SE & Co. KGaA

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2018, Feb – 2021, Oct) Leading Players
FIG 5 Recent strategies and developments: Lonza Group AG
FIG 6 Recent strategies and developments: Terumo Corporation
FIG 7 Recent strategies and developments: thermo fisher scientific, inc.
FIG 8 Swot analysis: thermo fisher scientific, inc.
FIG 9 Recent strategies and developments: Miltenyi Biotec B.V. & Co. KG
FIG 10 Recent strategies and developments: Sartorius AG

Purchase Full Report of
LAMEA Automated and Closed Cell Therapy Processing Systems Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL